Sporadic schwannomas and neurofibromas

Prevention
Article section 8 of 16.  Previous  Next

By Herbert B Newton MD

No measures are known to prevent the development of a neurofibroma or schwannoma in sporadic patients or those at risk from associated disorders (eg, neurofibromatosis type 1 and neurofibromatosis type 2).

In This Article

Introduction
Historical note and nomenclature
Clinical manifestations
Clinical vignette
Etiology
Pathogenesis and pathophysiology
Epidemiology
Prevention
Differential diagnosis
Diagnostic workup
Prognosis and complications
Management
Pregnancy
Anesthesia
References cited
Contributors